Fluorescence-based Assessment of LRP Activity: A Comparative Study

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 725-732

  Durdux, M ^a   Grunwald D , ^b   Gautier, T ^c   Ronot, X ^a   Boutonnat, J ^a,d  

^a LABORATOIRE TIMC IMAG   (France)

^b INSERM   (France)

^c INSTITUT ALBERT BONNIOT   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

Confocal laser scanning microscopy; Flow cytometry; Fluorescence correlation spectroscopy; LRP; Multidrug resistance

Indexed keywords

BUTYRIC ACID; CARBON 14; DAUNORUBICIN; LUNG RESISTANCE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMICAL REACTION KINETICS; CHRONIC MYELOID LEUKEMIA; COLON CARCINOMA; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN FUNCTION;

BUTYRATES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DAUNORUBICIN; FIBROSARCOMA; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; K562 CELLS; MICROSCOPY, CONFOCAL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; SPECTROMETRY, FLUORESCENCE; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 2442521399     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kitazono M, Sumizawa T, Takebayashi Y, Chen ZS, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T and Akiyama S: Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 19: 1647-1653, 1999.
2. Lehnert M: Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 6: 912-920, 1996.
3. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
4. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 5088: 1650-1654, 1992.
5. Muller M, Meijer C, Zaman G, Borst P, Scheper R, Mulder N, de Vries E and Jansen P: Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. PNAS 26: 13033-13037, 1994.
6. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG and, van der Valk P: Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 7: 1475-1479, 1993.
7. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC and Scheper RJ: The drug resistance-related protein LRP is the human major vault protein. Nat Med 6: 578-582, 1995.
8. Kong LB, Siva AC, Rome LH and Stewart PL: Structure of the vault, a ubiquitous cellular component. Structure Fold Des 4: 371-379, 1999.
9. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M and Rome LH: The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 5: 917-928, 1999.
10. Kickhoefer VA, Stephen AG, Harrington L, Robinson MO and Rome LH: Vaults and telomerase share a common subunit, TEP1. J Biol Chem 46: 32712-32717, 1999.
11. Chugani DC, Rome LH and Kedersha NL: Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci 106: 23-29, 1993.
12. Kedersha NL, Heuser JE, Chugani DC and Rome LH: Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol 2: 225-235, 1991.
13. Kickhoefer VA, Searles RP, Kedersha NL, Garber ME, Johnson DL and Rome LH: Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J Biol Chem 11: 7868-7873, 1993.
14. Kickhoefer VA, Rajavel KS, Scheffer GL, Dalton WS, Scheper RJ and Rome LH: Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 15: 8971-8974, 1998.
15. Scheffer GL, Schroeijers AB, Izquierdo MA, Wiemer EA and Scheper RJ: Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol 6: 550-556, 2000.
16. Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Belien JA, Giaccone G, Scheffer GL, Flens MJ, Pinedo HM, Kenemans P et al: Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 16: 1230-1237, 1995.
17. List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ and Dalton WS: Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 6: 2464-2469, 1996.
18. Ohno N, Tani A, Uozumi K, Hanada S, Furukawa T, Akiba S, Sumizawa T, Utsunomiya A, Arima T and Akiyama S: Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia. Blood 4: 1160-1165, 2001.
19. Kitazono M, Okumura H, Ikeda R, Sumizawa T, Furukawa T, Nagayama S, Seto K, Aikou T and Akiyama S: Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Int J Cancer 1: 126-131, 2001.
20. Schwille P KJ and Webb WW: Fluorescence correlation spectroscopy with single-molecule sensitivity on cell and model membranes. Cytometry 3: 176-182, 1999.
21. Newmeyer DD and Wilson KL: Egg extracts for nuclear import and nuclear assembly reactions. Methods Cell Biol 36: 607-634, 1991.
22. Boutonnat J, Bonnefoix T, Mousseau M, Seigneurin D and Ronot X: Coexpression of multidrug resistance involved proteins: a flow cytometric analysis. Anticancer Res 4C: 2993-2999, 1998.
23. Brock R and Jovin TM: Fluorescence correlation spectroscopy. Theory and applications. (Rigler R and Elson ES, eds). Berlin, Springer Verlag, 2001, 65.
24. Gray B, Askenasy N, Breslin E, Muirhead K et al: Novel far red and near infrared dyes for cell tracking in vivo. Proc Molecular Imaging in Cancer: Linking Biology, Function, and Clinical Applns.A12., In Vivo 2002.
25. den Boer ML, Pieters R, Kazemier KM, Rottier MMA, Zwaan CM, Kaspers GJL, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ and Veerman AJP: Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood 6: 2092-2098, 1998.
26. Berger W, Elbling L and Micksche M: Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int J Cancer 2: 293-300, 2000.
27. Damiani D, Michelutti A, Michieli M, Masolini P, Stocchi R, Geromin A, Ermacora A, Russo D, Fanin R and Baccarani M: P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. Br J Haematol 3: 519-527, 2002.
28. Calcabrini A, Meschini S, Stringaro A, Cianfriglia M, Arancia G and Molinari A: Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. Histochem J 10: 599-606, 2000.
29. Legrand O, Simonin G, Perrot JY, Zittoun R and Marie JP: Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 12: 4480-4488, 1998.
30. Alton P and Harris A: The role of DNA topoisomerases II in drug resistance. Br J Haematol 2: 241-245, 1993.